QValid AB
ActiveKey figures
Key figures
2024/25Summary: QValid AB
What kind of company is it?
QValid AB (org. no. 559294-8367) is a limited company (AB). The company was registered in 2021 and has existed for 5 years. Registered seat: Malmö. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).
How is the company doing financially?
Net sales in financial year 2025 were 633 366 kr, up 32,6 % on the previous year (477 542 kr). From 2022 to 2025, net sales declined by an average of 26,4 % per year. Net profit for 2025 was 197 710 kr (31,2 % of net sales). The company was profitable in 3 of the 4 reported financial years. Employees in financial year 2025: 2 (previous year: 1). Net sales per employee were 316 683 kr. At the end of financial year 2025, total assets were 771 918 kr and equity 521 778 kr (equity ratio 67,6 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 187 550 kr.
Summary of annual reports2022–2025
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Sales revenue | 1 589 634 | 308 875 | 477 542 | 633 366 |
| Profit for the reporting year | 470 924 | −261 971 | 277 665 | 197 710 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 814 820 | 385 732 | 550 644 | 771 918 |
| Total liabilities | 318 896 | 339 329 | 226 576 | 250 140 |
| Total equity | 495 924 | 46 403 | 324 068 | 521 778 |
| Employees | 2 | 2 | 1 | 2 |
| Proposed dividend | 187 550 | — | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.